OIS: Francine Behar-Cohen Presents “Innovative Non-Viral Therapies for the Treatment of Ocular Diseases”

OIS: Francine Behar-Cohen Presents “Innovative Non-Viral Therapies for the Treatment of Ocular Diseases”

OIS: Francine Behar-Cohen Presents “Innovative Non-Viral Therapies for the Treatment of Ocular Diseases” 150 150 Eyevensys

Watch Eyevensys Founder and Chief Innovation Officer, Prof. Francine Behar-Cohen, present at the OIS Ocular Drug Delivery Meeting, providing details about our innovative non-viral gene therapies for the treatment of ocular diseases and our active pipeline and strategy.

OIS Drug Delivery Innovation Showcase – Eyevensys from Healthegy on Vimeo.